DelveInsight's "ROZLYTREK Market Size, Forecast, and Market Insight Report" highlights the details around ROZLYTREK, an inhibitor of the ...

During embryonic development, the intestine of the Drosophila fly divides into distinct chambers thanks to the formation of ...

Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, ...

St. Jude researchers identified a protein, voltage-dependent anion channel 2 (VDAC2), that tumors use as a “signal jammer” to prevent cancer cell death and evade the immune system’s functioning.

Why do medications that are supposed to help patients with chronic inflammatory diseases sometimes lead to blood clots?

Researchers have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer's disease.

Bone morphogenetic proteins (BMPs) directly affect the osteogenic differentiation of stem cells and are integral to bone ...

In Nature Neuroscience, UConn School of Medicine researchers have revealed a new scientific clue that could unlock the key cellular pathway leading to devastating neurodegenerative diseases like ...

The combination of sintilimab and fruquintinib received conditional approval from China’s National Medical Products Administration (NMPA) for the treatment of patients with advanced endometrial cancer ...

The polyoma project was moving slowly. With my background in oncology and my emerging expertise in tyrosine kinase signaling, it seemed to me that I should be working on a human disease caused by ...

Institute for Atmospheric and Climate Science, ETH Zürich, Zurich 8092, Switzerland ...